ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 76 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $210,000 | +21.4% | 66,715 | 0.0% | 0.00% | – |
| Q4 2016 | $173,000 | -23.8% | 66,715 | +14.6% | 0.00% | – |
| Q3 2016 | $227,000 | +44.6% | 58,240 | 0.0% | 0.00% | – |
| Q2 2016 | $157,000 | +19.8% | 58,240 | +71.1% | 0.00% | – |
| Q1 2015 | $131,000 | -42.8% | 34,032 | 0.0% | 0.00% | – |
| Q4 2014 | $229,000 | +22.5% | 34,032 | 0.0% | 0.00% | – |
| Q3 2014 | $187,000 | -46.4% | 34,032 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $349,000 | -16.5% | 34,032 | -2.3% | 0.00% | 0.0% |
| Q1 2014 | $418,000 | +20.5% | 34,839 | +13.7% | 0.00% | 0.0% |
| Q4 2013 | $347,000 | +5.2% | 30,639 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $330,000 | +30.4% | 30,639 | +12.4% | 0.00% | 0.0% |
| Q2 2013 | $253,000 | – | 27,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |